Sri Lanka vs Uganda: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Sri Lanka
0.3%
in 2024
Uganda
0.3%
in 2024
Sri Lanka rank
67th
Uganda rank
67th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Sri Lanka
- Uganda
How they compare
Sri Lanka currently reports 0.3% against 0.3% in Uganda, a difference of 0.0%.
Across all 10 years both countries report, Uganda has been ahead every year.
Sri Lanka ranks 67th and Uganda ranks 67th of 215 countries.
Uganda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sri Lanka | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.4% | 0.1% | Uganda |
| 2020s | 0.3% | 0.4% | 0.1% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Sri Lanka or Uganda?
- Sri Lanka, at 0.3% against 0.3% in Uganda as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Sri Lanka and Uganda?
- 0.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Sri Lanka and Uganda?
- 10 years are reported by both, from 2015 to 2024.
- How do Sri Lanka and Uganda rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Sri Lanka ranks 67th and Uganda ranks 67th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.